PUBLISHER: QYResearch | PRODUCT CODE: 1091514
PUBLISHER: QYResearch | PRODUCT CODE: 1091514
High-performance liquid chromatography (HPLC) systems are used to analyze and/or purify liquid mixtures. Analytical HPLC systems are used in the food safety, pharmaceutical, and manufacturing industries, as well as in medical and research laboratories. Two of the most common types of analytical HPLC systems are normal phase HPLC and reversed phase HPLC. Normal phase uses a polar stationary phase and a non-polar mobile phase to separate components of a mixture, while reversed phase HPLC uses phases with the opposite polarities of normal phase HPLC. The sample liquid is mixed with the mobile phase and run through a column that contains the stationary phase. The way the sample moves through the column is the basis for the analysis.
Due to the COVID-19 pandemic, the global Analytical HPLC Systems market size was value at US$ 770.95 million in 2021 and is forecast to be a readjusted size of US$ 1095.48 million by 2028 with a CAGR of 5.52% during the forecast period 2022-2028.
The global main manufacturers of Analytical HPLC Systems include Showa Denko K.K., Shimadzu, Thermo Fisher, Agilent, PerkinElmer, Waters, and etc. In 2021, the global six largest players have a share approximately 64.19% in terms of revenue.
The North America Analytical HPLC Systems market size was US$ 281.89million in 2021, while China was about US$ 113.81million. The proportion of the China was 14.76% in 2021 and it is predicted that the share will reach 21.73% in 2028, trailing a CAGR of 10.39% through the analysis period. As for the Europe Analytical HPLC Systems landscape, Germany is projected to reach US$ 54.75 million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is 4.42% and 3.86% respectively for the next 6-year period.
Fully considering the economic change by the COVID-19, Normal Phase HPLC accounting for 29.33% of the Analytical HPLC Systems global market in 2021, is projected to value US$ 286.11 million by 2028, growing at a revised 3.96% CAGR from 2022 to 2028. While Pharmaceutical segment is altered to an 5.32% CAGR throughout this forecast period and will hold a share about 45.85% in 2028.
The global Analytical HPLC Systems market is segmented by region (country), company, by Flow Rate, and by Application. Players, stakeholders, and other participants in the global Analytical HPLC Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Flow Rate, and by Application for the period 2017-2028.